|
|
||||||||
)From the Division of Gynecology and Obstetrics, Endocrine Section, Albert Einstein Medical Center, Northern Division, Philadelphia, Pa
Abstract
The effects or prostaglandin F2
on the spermatozoa-cervical mucus system was evaluated clinically in vitro. A modification of the tube technic described by Kanatakc and Davajan was used to determine the effect of PGFM on the motility, penetration and drive of spermatozoa through treated mucus. The results show a significant increase in all of these characteristics when the pharmacologic and physiologic level (250 µµg/mt) of PGF2
is used. The greatest effect in vitro was observed with cervical mucus obtained within 48 hours of probable ovulation.
This article has been cited by other articles:
![]() |
S. E. Brown, J. P. Toner, J. A. Schnorr, S. C. Williams, W. E. Gibbons, D. de Ziegler, and S. Oehninger Vaginal misoprostol enhances intrauterine insemination Hum. Reprod., January 1, 2001; 16(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |